Status: approved in U.S., not actively marketed

Organizations involved:

Massachusetts Biological Laboratories – Manuf.; Tech.; USA mark.

State of Massachusetts – Parent

Description: Immune Globulin Intravenous (Human) is a formulation of immune globulin obtained from fractionated pooled Plasma intended for intramuscular injection.

Nomenclature: Immune Globulin (IGIM)/Mass. [BIO]; Immune Globulin (Human) [FDA]; Immune Serum Globulin [FDA former]; gamma globulin [SY]; IGIM [SY]; intramuscular immune globulin (IMIG) [SY]; immune serum globulin [SY]

Companies.: Approval for manufacture is held by the Massachusetts Biological Laboratories, affiliated with the State of Massachusetts.

Approvals: Date = 19430908; first approval

Indications: product insert/labeling not available

Status: This product is approved, but it is not commercially marketed. It is likely sold to other companies for further processing (e.g., for manufacture of IGIV; and/or used within the State of Massachusetts).